Figure 3 | Scientific Reports

Figure 3

From: Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study

Figure 3

(a) Kaplan-Meyer curve representing overall survival of the whole patients, pre-NDE patients and post-NDE patients. The red line represents overall survival curve of whole patients. The green line with ribbon represents overall survival curve with 95% confidence interval of pre-NDE patients. The blue line with ribbon represents overall survival with 95% confidenve interval of post-NDE patients. pre-NDE, pre new drug era; post-NDE, post new drug era. (b) Kaplan-Meyer curve of overall survival between pre-NDE and post-NDE after IPTW adjusting. The red and green line with ribbon represents overall survival with 95% confidence interval of pre-NDE and post-NDE, respectively. pre-NDE, pre new drug era; post-NDE, post new drug era; IPTW, inverse probability of treatment weighting.

Back to article page